Oxford Immunotec
(OXFD)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 50,365 | 76,581 | 12,965 | 2,334 |
| Receivables | 6,823 | 4,754 | 5,400 | 2,211 |
| Inventories | 6,425 | 5,450 | 3,073 | 1,975 |
| TOTAL | $66,368 | $89,027 | $22,780 | $7,549 |
| Non-Current Assets | ||||
| PPE Net | 4,537 | 2,964 | 2,249 | 1,677 |
| Intangibles | 323 | 331 | 107 | 54 |
| Other Non-Current Assets | 2,621 | 422 | 347 | 359 |
| TOTAL | $7,481 | $3,717 | $2,703 | $2,090 |
| Total Assets | $73,849 | $92,744 | $25,483 | $9,639 |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 2,505 | 2,480 | 1,833 | 1,722 |
| Accrued Expenses | 7,070 | 6,936 | 3,962 | 2,333 |
| TOTAL | $11,568 | $11,133 | $8,391 | $4,273 |
| Non-Current Liabilities | ||||
| Long Term Debt | 454 | 563 | 143 | 140 |
| Deferred Revenues | 1,993 | 1,540 | 908 | 71 |
| Other Non-Current Liabilities | 1,218 | 296 | 0 | 0 |
| TOTAL | $1,672 | $859 | $143 | $140 |
| Total Liabilities | $13,240 | $11,992 | $8,534 | $4,413 |
| Shareholders' Equity | ||||
| Shares Outstanding, K | 22,510 | 17,266 | N/A | N/A |
| Common Shares | 192 | 188 | 24 | 14 |
| Retained earnings | -121,829 | -99,655 | -90,991 | -76,108 |
| Other shareholders' equity | -4,570 | -3,748 | -3,622 | -3,967 |
| TOTAL | $60,609 | $80,752 | $16,949 | $5,226 |
| Total Liabilities And Equity | $73,849 | $92,744 | $25,483 | $9,639 |